Ursodeoxycholic acid reduces expression of heat shock proteins in primary biliary cirrhosis

Liver

Volumn 20, Issue 1, 2000, Pages 78-87

  Sakisaka, Shotaro ^a   Koga, Hironori ^a   Sasatomi, Kurumi ^a   Ohishi, Masahito ^a   Kawaguchi, Takumi ^a   Harada, Masaru ^a   Taniguchi, Eitaro ^a   Uchimura, Yasuyo ^a   Ueno, Takato ^a   Sata, Michio ^a   Tanikawa, Kyuichi ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Immunohistochemistry; Primary sclerosing cholangitis; Viral hepatitis

Indexed keywords

HEAT SHOCK PROTEIN; HEAT SHOCK PROTEIN 70; UBIQUITIN; URSODEOXYCHOLIC ACID;

ADULT; AGED; ARTICLE; BILE DUCT; CLINICAL ARTICLE; CONTROLLED STUDY; EPITHELIUM CELL; FEMALE; HEPATITIS C; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; LIVER BIOPSY; LIVER CELL; MALE; PRIMARY BILIARY CIRRHOSIS; PRIMARY SCLEROSING CHOLANGITIS; PROTEIN EXPRESSION;

ADULT; AGED; BILE DUCTS, INTRAHEPATIC; CELL COUNT; CHOLAGOGUES AND CHOLERETICS; CHOLANGITIS, SCLEROSING; EPITHELIAL CELLS; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HEPATITIS C, CHRONIC; HSP70 HEAT-SHOCK PROTEINS; HUMANS; IMMUNOBLOTTING; LIVER; LIVER CIRRHOSIS, BILIARY; MALE; MIDDLE AGED; UBIQUITINS; URSODEOXYCHOLIC ACID;

EID: 0033975561     PISSN: 01069543     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0676.2000.020001078.x     Document Type: Article

References (48)

1. WIESNER R H, LARUSSO N F, LUDWIG J, DICKSON E R. Comparison of the clinicopathologic features of primary sclerosing cholangitis and primary biliary cirrhosis. Gastroenterology 1985; 88: 108-14.
2. LINDOR K D, DICKSON E R, BALDUS W P, et al. Ursodeoxycholic acid in the treatment of primary biliary cirrhosis. Gastroenterology 1994; 106: 1284-90.
3. KOGA H, SAKISAKA S, OHISHI M, SATA M, TANIKAWA K. Nuclear DNA fragmentation and expression of Bcl-2 in primary biliary cirrhosis. Hepatology 1997; 25: 1077-84.
4. POUPON R, CHRÉTIEN Y, POUPON R E, BALLET F, CALMUS Y, DARNIS F. Is ursodeoxycholic acid an effective treatment for primary biliary cirrhosis? Lancet 1987; i: 834-6.
5. LEUSCHNER U, FISCHER H, KURTZ W, et al. Ursodeoxycholic acid in primary biliary cirrhosis: results of an controlled double-blind trial. Gastroenterology 1989; 97: 1268-74.
6. POUPON R E, BALKAU B, ESCHWÉGE E, POUPON R, UDCA-PBC STUDY GROUP. A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis. N Engl J Med 1991; 324: 1548-54.
7. POUPON R E, POUPON R, BALKAU B, THE UDCA-PBC STUDY GROUP. Ursodiol for the long-term treatment of primary biliary cirrhosis. N Engl J Med 1994; 330: 1342-7.
8. TARAO K, SHIMIZU A, OHKAWA S, et al. Increased uptake of bromodeoxyuridine by hepatocytes from early stage of primary biliary cirrhosis. Gastroenterology 1991; 100: 725-30.
9. RUDI J, WALDHERR R, RAEDSCH R. KOMMERELL B. Hepatocyte proliferation in primary biliary cirrhosis as assessed by proliferating cell nuclear antigen and Ki-67 antigen labelling. J Hepatol 1995; 22: 43-9.
10. KOSKINAS J, WINROW V R, BIRD G L A, et al. Hepatic 60-kDa heat-shock protein responses in alcoholic hepatitis. Hepatology 1993; 17: 1047-51.
11. WINROW V R, BIRD G L, KOSHINAS J, BLAKE D R, WILLIAMS R, ALEXANDER G J M. Circulating IgA antibody against a 65 kDa heat shock protein in acute alcoholic hepatitis. J Hepatol 1994; 20: 359 63.
12. JORGE A D, STATI A O, ROIG L V, ONCE G, JORGE O A , CIOCCA D R. Steroid receptors and heat-shock proteins in patients with primary biliary cirrhosis. Hepatology 1993; 18: 1108-14.
13. BROOMÉ U, SCHEYNIUS A, HULTCRANTZ R. Induced expression of heat-shock protein on biliary epithelium in patients with primary sclerosing cholangitis and primary biliary cirrhosis. Hepatology 1993; 18: 298-303.
14. YAMAGUCHI H, MIURA H. OHSUMI K, et al. Detection and characterization of antibodies to bacterial heat-shock protein 60 in sera of patients with primary biliary cirrhosis. Microbiol Immunol 1994; 38: 483-7.
15. DYKE R A V, MOSTAFAPORT S, MARSH H M , LI Y, CHOPP M. Immunocytochemical detection of the 72-kDa heat shock protein in halothane-induced hepatotoxicity in rats. Life Sci 1991; 50:41-5.
16. OMAR R, PAPPOLLA M, SARAN B. Immunocytochemical detection of the 70-kd heat shock protein in alcoholic liver disease. Arch Pathol Lab Med 1990; 114: 589-92.
17. SCHOENIGER L O, ANDREONI K A, OTT G R, et al. Induction of heart-shock gene expression in postischemic pig liver depends on superoxide generation. Gastroenterology 1994; 106: 177-84.
18. TACCHINI L, SCHIAFFONATI L, PAPPALARDO C, GATTI S, BERNELLI-ZAZZERA A. Expression of HSP 70, immediateearly response and heme oxygenase genes in ischemic-reperfused rat liver. Lab Invest 1993; 68: 465-71.
19. KIM Y-M. VERA M E, WATKINS S C, BILLIAR T R. Nitric oxide protects cultured rat hepatocytes from turner necrosis factor-α-induced apoptosis by inducing heat shock protein 70 expression. J Biol Chem 1997; 272: 1402-11.
20. OHTA M, MARCEAU N, PERRY G, et al. Ubiquitin is present on the cytokeratin intermediate filaments and Mallory bodies of hepatocytes. Lab Invest 1988; 59: 848-856.
21. SCHEUER P J. Liver Biopsy Interpretation. 3rd ed. London: Bailliére Tindal, 1980.
22. ZHONG Y, SAITOH T, MINASE T, SAWADA N, ENOMOTO K, MORI M. Monoclonal antibody 7H6 reacts with a novel tight junction-associated protein distinct from ZO-1, cingulin and ZO-2. J Cell Biol 1993; 120: 477-83.
23. LAEMMLI U K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227: 680-5.
24. TOWBIN H, STAEHELIN T, GORDON J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Biotechnol 1992; 24: 145-9.
25. SAKISAKA S, WATANABE M, TATEISHI H, et al. Erythropoietin production in hepatocellular carcinoma cells associated with polycythemia: immunohistochemical evidence. Hepatology. 1993; 18: 1357-62.
26. SAKISAKA S, GONDO K, YOSHITAKE M, et al. Functional differences between hepatocytes and biliary epithelial cells in handling polymeric immunoglobulin A2 in human, rat, and guinea pig. Hepatology 1996; 24: 398-406.
27. CUERVO A M, DICE J F, KNEWIN E. A population of rat liver lysosomes responsible for the selective uptake and degradation of cytosolic proteins. J Biol Chem 1997; 272: 5606-15.
28. LINDQUIST S. The heat-shock response. Annu Rev Biochem 1986; 55: 1151-91.
29. KUSHER D I, WARE C F, GOODING L R. Induction of the heat shock response protects cells from lysis by tumor necrosis factor. J Immunol 1990; 145: 2925-31.
30. SAKISAKA S, ANNO H, KUMASHIRO R, et al. The cytotoxicity of chenodeoxycholic acid (CDCA) and ursodeoxycholic acid (UDCA) on primary cultured hepatocytes, and cytoprotective effect of polyenephosphatidylcholine (PPC). Acta Hepatol Jpn 1984; 25: 350-8.
31. GRAHAM J M, NORTHFIELD T C. Solubilization of lipids from hamster bile canalicular and contiguous membranes and from human erythrocyte membranes by conjugated bile salts. Biochem J 1987; 242: 825-34.
32. GUMUCIO J J, BALABAUD C, MILLER D L, et al. Bile secretion and liver cell heterogeneity. J Lab Clin Med 1978; 91: 350-62.
33. HILLAIRE S, BOUCHER E, CALMUS Y, et al. Effects of bile acids and cholestasis on major histocompatibility complex class 1 in human and rat hepatocytes. Gastroenterology 1994; 107: 781-8.
34. KAJI K, NAKANUMA Y, SASAKI M, et al. Hepatic bile duct injuries in chronic hepatitis C: histopathologic and immunohistochemical studies. Mod Pathol 1994; 7: 937-45.
35. DORIA M I, SHEPARD K V, LEVIN B, RIDDELL R. Liver pathology following hepatic arterial infusion chemotherapy. Hepatic toxicity with FUDR. Cancer 1986; 58: 855-61.
36. KOBAYASHI S, NAKANUMA Y, TERADA T, MATSUI O. Postmortem survey of bile duct necrosis and biloma in hepatocellular carcinoma after transcatheter chemoembolization therapy: relevalence to microvascular damages of peribiliary capillary plexus. Am J Gastroenterol 1993; 9: 1410-5.
37. BATTA A K, SALEN G, ARORA R, et al. Effect of ursodeoxycholic acid on bile acid metabolism in primary biliary cirrhosis. Hepatology 1989; 10: 414-9.
38. HOFFMAN A F. Bile acid hepatotoxicity and the rationale of UDCA therapy in chronic cholestatic liver disease: some hypothesis. In: Paumgartner G, Stiehl A, Barbara L, Roda E, eds. Strategies for the treatment of hepatobiliary diseases. Dordrecht: Kluwer Academic Publishers, 1990: 13-33.
39. HEUMAN D M, PANDAK W M, HYLEMON P B, VLAHCEVIC Z R. Conjugates of ursodeoxycholate protect against cytotoxicity of more hydrophobic bile salts: in vitro studies in rat hepatocytes and erythrocytes. Hepatology 1991; 14: 920-6.
40. SCHMUCKER D L, OHTA M, KANAI S, SATO Y, KITANI K. Hepatic injury induced by bile salts: correlation between biochemical and morphological events. Hepatology 1990; 12: 1216-21.
41. CALMUS Y, GANE P, ROUGER P, POUPON R. Hepatic expression of class I and class II major histocompatibility complex molecules in primary biliary cirrhosis: effect of ursodeoxycholic acid. Hepatology 1990; 11: 12-5.
42. YOSHIKAWA M, TSUJI T, MATSUMURA K, et al. Immunomodulatory effects of ursodeoxycholic acid on immune responses. Hepatology 1992; 16: 358-64.
43. SAEKI R, OGINO H, KANEKO S, UNOURA M, KOBAYASHI K. Effects of chenodeoxycholic and ursodeoxycholic acids on interferon-γ production by peripheral blood mononuclear cells from patients with primary biliary cirrhosis. Gastroenterology 1995; 30: 739-44.
44. TANAKA H, MAKINO Y, MIURA T, et al. Ligand-independent activation of the glucocorticoid receptor by ursodeoxycholic acid. Repression of IFN-γ-induced MHC class II gene expression via a glucocorticoid receptor-dependent pathway. J Immunol 1996; 156: 1601-8.
45. JAZRAWI R P, CAESTECKER J S D, GOGGIN P M, et al. Kinetics of hepatic bile acid handling in cholestatic liver disease: effect of ursodeoxycholic acid. Gastroenterology 1994; 106: 134-42.
46. RODRIGUES C M P, FAN G, MA X, KREN B T, STEER C J. A novel role for ursodeoxycholic acid in inhibiting apoptosis by modulating mitochondrial membrane perturbation. J Clin Invest 1998; 101: 2790-9.
47. PERDIGOTO R, WIESNER R H. Progression of primary biliary cirrhosis with ursodeoxycholic acid therapy. Gastroenterology 1992; 102: 1389-91.
48. COMBES B, CARITHERS R L, MADDREY W C, et al. A randomized, double-blind, placebo-controlled trial of ursodeoxycholic acid in primary biliary cirrhosis. Hepatology 1995; 22: 759-66.